Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -49.73% is in line with its 5-year average of -46.55%, around the middle of its 5-year range (-64.99%–-20.11%).
As of the fiscal period ended Tuesday, June 30, 2026. 11.10% above its 12-month average of -55.95%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -49.73%.
RETURN ON INVESTED CAPITAL (ROIC)
-49.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-55.95%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-50.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-46.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+11.10%
CURRENT VS 3Y AVG
+0.80%
CURRENT VS 5Y AVG
-6.84%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-39.53%
vs the sector median at left
SOPHiA GENETICS S.A.
Market Cap
$619.15M
Return on Invested Capital (ROIC)
-49.73%
TTM Avg
-55.95%
3Y Avg
-50.13%
5Y Avg
-46.55%
Market Cap
$611.57M
Return on Invested Capital (ROIC)
-26.94%
TTM Avg
-40.40%
3Y Avg
-38.31%
5Y Avg
-45.27%
Market Cap
$630.63M
Return on Invested Capital (ROIC)
-17.48%
TTM Avg
-24.56%
3Y Avg
-18.89%
5Y Avg
-16.21%
Market Cap
$632.16M
Return on Invested Capital (ROIC)
-90.42%
TTM Avg
-73.13%
3Y Avg
-82.56%
5Y Avg
-61.25%
Market Cap
$634.30M
Return on Invested Capital (ROIC)
12.93%
TTM Avg
-31.02%
3Y Avg
-34.46%
5Y Avg
-44.99%
Market Cap
$638.20M
Return on Invested Capital (ROIC)
-42.02%
TTM Avg
-66.01%
3Y Avg
-48.82%
5Y Avg
-55.42%
Market Cap
$597.55M
Return on Invested Capital (ROIC)
58.60%
TTM Avg
17.42%
3Y Avg
-47.16%
5Y Avg
-23.48%
Market Cap
$596.01M
Return on Invested Capital (ROIC)
-20.75%
TTM Avg
-20.15%
3Y Avg
-33.64%
5Y Avg
-24.57%
Market Cap
$584.48M
Return on Invested Capital (ROIC)
-11.80%
TTM Avg
-7.26%
3Y Avg
-5.22%
5Y Avg
9.70%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SOPHiA GENETICS S.A. (SOPH) | $619.15M | -49.73% | -55.95% | -50.13% | -46.55% |
| Climb Bio, Inc. (CLYM)vs › | $611.57M | -26.94% | -40.40% | -38.31% | -45.27% |
| OmniAb, Inc. (OABI)vs › | $630.63M | -17.48% | -24.56% | -18.89% | -16.21% |
| Prime Medicine, Inc. (PRME)vs › | $632.16M | -90.42% | -73.13% | -82.56% | -61.25% |
| Zevra Therapeutics, Inc. (ZVRA)vs › | $634.30M | 12.93% | -31.02% | -34.46% | -44.99% |
| Aura Biosciences, Inc. (AURA)vs › | $638.20M | -42.02% | -66.01% | -48.82% | -55.42% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $597.55M | 58.60% | 17.42% | -47.16% | -23.48% |
| AngioDynamics, Inc. (ANGO)vs › | $596.01M | -20.75% | -20.15% | -33.64% | -24.57% |
| Fulgent Genetics, Inc. (FLGT)vs › | $584.48M | -11.80% | -7.26% | -5.22% | 9.70% |
| OrthoPediatrics Corp. (KIDS)vs › | $583.31M | -4.97% | -6.49% | -6.53% | -6.86% |
ROIC
-49.7%
ROE
-97.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -49.73% |
| 2026-03-31 | -64.99% |
| 2025-12-31 | -62.67% |
| 2025-09-30 | -55.24% |
| 2025-06-30 | -47.09% |
| 2025-03-31 | -54.21% |
| 2024-12-31 | -51.80% |
| 2024-09-30 | -46.39% |
| 2024-06-30 | -45.42% |
| 2024-03-31 | -49.51% |
| 2023-12-31 | -43.88% |
| 2023-09-30 | -40.10% |
| 2023-06-30 | -40.73% |
| 2023-03-31 | -40.50% |
| 2022-12-31 | -40.47% |
| 2022-09-30 | -42.13% |
| 2022-06-30 | -36.79% |
| 2022-03-31 | -30.83% |
| 2021-12-31 | -24.52% |
| 2021-09-30 | -20.11% |
| 2021-06-30 | -64.06% |
| 2021-03-31 | -45.16% |
| 2020-12-31 | -32.97% |
